Ivacaftor


( Last Updated : May 1, 2014)
Generic Name:
Ivacaftor
Project Status:
Complete
Therapeutic Area:
Cystic Fibrosis, CFTR gating mutations
Manufacturer:
Vertex Pharmaceuticals Canada
Call for patient/clinician input open:
Brand Name:
Kalydeco
Project Line:
Reimbursement Review
Project Number:
SR0379-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Cystic Fibrosis (CFTR gating mutations)
Recommendation Type:
List with criteria/condition
Final Recommendation: